Free Trial

Short Interest in iHuman Inc. Sponsored ADR (NYSE:IH) Expands By 364.7%

iHuman logo with Consumer Discretionary background

Key Points

  • Short interest in iHuman Inc. experienced a significant increase of 364.7% in July, rising from 1,700 shares to 7,900 shares, although only 0.0% of the company's shares are currently short sold.
  • Institutional investors have shown interest, with Acadian Asset Management and Virtu Financial acquiring new positions worth $32,000 and $26,000 respectively, while Citadel Advisors increased their stake by 24.3%.
  • iHuman's shares traded at $2.79, with a market cap of $145.19 million, and the company reported a $0.07 EPS for the latest quarter alongside a revenue of $29.00 million.
  • Looking to export and analyze iHuman data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

iHuman Inc. Sponsored ADR (NYSE:IH - Get Free Report) was the target of a large increase in short interest in July. As of July 31st, there was short interest totaling 7,900 shares, anincreaseof364.7% from the July 15th total of 1,700 shares. Currently,0.0% of the company's shares are short sold. Based on an average trading volume of 28,100 shares, the days-to-cover ratio is currently 0.3 days. Based on an average trading volume of 28,100 shares, the days-to-cover ratio is currently 0.3 days. Currently,0.0% of the company's shares are short sold.

Institutional Investors Weigh In On iHuman

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Acadian Asset Management LLC acquired a new position in shares of iHuman during the 1st quarter worth $32,000. Virtu Financial LLC acquired a new position in shares of iHuman during the 1st quarter worth $26,000. Finally, Citadel Advisors LLC increased its stake in shares of iHuman by 24.3% during the 4th quarter. Citadel Advisors LLC now owns 47,683 shares of the company's stock worth $81,000 after purchasing an additional 9,314 shares during the last quarter. Hedge funds and other institutional investors own 4.92% of the company's stock.

iHuman Stock Performance

Shares of NYSE:IH traded up $0.04 during mid-day trading on Friday, hitting $2.79. The stock had a trading volume of 6,225 shares, compared to its average volume of 46,565. The company has a market cap of $145.19 million, a PE ratio of 10.34 and a beta of 0.39. iHuman has a 12-month low of $1.47 and a 12-month high of $3.60. The company's 50 day moving average is $2.60 and its 200-day moving average is $2.30.

iHuman (NYSE:IH - Get Free Report) last issued its quarterly earnings results on Thursday, June 26th. The company reported $0.07 EPS for the quarter. iHuman had a net margin of 11.44% and a return on equity of 11.00%. The business had revenue of $29.00 million during the quarter.

iHuman Company Profile

(Get Free Report)

iHuman Inc provides intellectual development products to individual users, kindergartens, and distributors in the People's Republic of China. The company offers interactive and self-directed learning apps, including iHuman Chinese, iHuman ABC, iHuman Pinyin, iHuman Magic Thinking, iHuman Books, iHuman Stories, iHuman Reading, iHumanpedia, iHuman Kids Workout, iHuman Coding, iHuman Fun Idioms, iHuman Little Artists, iHuman Writing, iHuman Fantastic Friends, and iHuman Readers; bekids Coding, bekids Coloring, bekids Reading, bekids Puzzle, bekids Academy, and Gogo Town; and Aha World, an open-ended interactive app that nurtures a desire for discovery.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in iHuman Right Now?

Before you consider iHuman, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and iHuman wasn't on the list.

While iHuman currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s Soaring Valuation—Justified or Overhyped?
3 Stocks With Explosive Upside
September Slowdown: 3 Stocks to Buy When the Pullback Comes

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines